ID

42265

Descripción

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 19.03.2021 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS, a multi-center cohort study, has been created to get more in-depth knowledge about the epidemiology and clinical course of patients infected with SARS-CoV-2. Initiated by the ESCMID Emerging Infections Task Force (EITaF) and the German Infectious Disease Society, and supported by all German Centers for Health Research (DZG), LEOSS has developed into an international network of contributors. Via an integrative research approach with anonymous recruitment and collection of routine data in an open science context, LEOSS is building a uniform clinical dataset and providing real-time analyses. For more information feel free to explore https://leoss.net/. This document is for the HIV sub-cohort. All questions refer to the day of diagnosis (diagnosis means first positive virus result). Please note that only cases with known outcome are collected at LEOSS! If a text field can't be filled out, note 'ND' (for not determined).

Link

https://leoss.net

Palabras clave

Versiones (3)
  1. 13/11/20 13/11/20 -
  2. 27/11/20 27/11/20 -
  3. 24/4/21 24/4/21 -
Titular de derechos de autor

LEOSS

Subido en

24 de abril de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

Inglés

HIV sub-cohort

1 formularios  
  1. StudyEvent: ODM
    1. HIV sub-cohort
HIV transmission risk
Descripción

HIV transmission risk

Alias
UMLS CUI-1
C0019682
UMLS CUI-2
C0035648
UMLS CUI-3
C1443844
Men having sex with men
Descripción

Men having sex with men

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2827413
Heterosexual contacts
Descripción

Heterosexual contacts

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4272228
Injection drug use
Descripción

Injection drug use

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0086190
UMLS CUI [1,2]
C1272883
Patient from an endemic area
Descripción

Patient from HIV endemic area

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3258107
UMLS CUI [1,2]
C0277550
UMLS CUI [1,3]
C0019682
Blood transfusion (excl. Haemophilia)
Descripción

Blood transfusion (excl. Haemophilia)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005841
UMLS CUI [1,2]
C1705847
UMLS CUI [1,3]
C0684275
Haemophilia
Descripción

Haemophilia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0684275
Other HIV transmission risk
Descripción

Other HIV transmission risk

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0035648
UMLS CUI [1,3]
C1443844
UMLS CUI [1,4]
C0205394
Indicate other HIV transmission risk:
Descripción

Indicate other HIV transmission risk

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0035648
UMLS CUI [1,3]
C1443844
UMLS CUI [1,4]
C0205394
UMLS CUI [1,5]
C1521902
Unknown HIV transmission risk
Descripción

Unknown HIV transmission risk

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0439673
UMLS CUI [1,2]
C0035648
UMLS CUI [1,3]
C1443844
UMLS CUI [1,4]
C0205394
Does the patient receive current antiretroviral therapy?
Descripción

Does the patient receive current antiretroviral therapy?

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C0521116
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
Descripción

Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C0162714
UMLS CUI [2,1]
C0521116
UMLS CUI [2,2]
C0674432
UMLS CUI [3,1]
C0521116
UMLS CUI [3,2]
C0292818
UMLS CUI [4,1]
C0521116
UMLS CUI [4,2]
C1435444
UMLS CUI [5,1]
C0521116
UMLS CUI [5,2]
C1145759
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
Descripción

Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C0376601
UMLS CUI [2,1]
C0521116
UMLS CUI [2,2]
C1871526
UMLS CUI [3,1]
C0521116
UMLS CUI [3,2]
C3253985
UMLS CUI [4,1]
C0521116
UMLS CUI [4,2]
C4507568
UMLS CUI [5,1]
C0521116
UMLS CUI [5,2]
C2606637
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Descripción

Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C3541376
UMLS CUI [2,1]
C0521116
UMLS CUI [2,2]
C0674428
UMLS CUI [3,1]
C0521116
UMLS CUI [3,2]
C0132326
UMLS CUI [4,1]
C0521116
UMLS CUI [4,2]
C1566826
UMLS CUI [5,1]
C0521116
UMLS CUI [5,2]
C4045491
Nucleoside analog reverse-transcriptase inhibitors
Descripción

Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C3537103
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
Descripción

Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C1449715
UMLS CUI [2,1]
C0521116
UMLS CUI [2,2]
C1667052
UMLS CUI [3,1]
C0521116
UMLS CUI [3,2]
C0537439
In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
Descripción

In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C0449238
UMLS CUI-3
C0332152
UMLS CUI-4
C5203676
UMLS CUI-5
C1511790
In case of antiretroviral therapy: for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
Descripción

Please indicate the number of months antiretroviral therapy had been taken.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1963724
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
Descripción

Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C3665894
UMLS CUI-3
C1704686
UMLS CUI-5
C0347984
UMLS CUI-6
C5203670
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
Descripción

Antiretroviral therapy changed / started during SARS-Cov-2 infection

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1963724
UMLS CUI [1,2]
C3665894
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C5203670
UMLS CUI [2,1]
C1963724
UMLS CUI [2,2]
C1704686
UMLS CUI [2,3]
C0347984
UMLS CUI [2,4]
C5203670
Please indicate the regimen at the end of the follow-up period
Descripción

Please indicate the regimen at the end of the follow-up period

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C1276413
UMLS CUI-3
C1522577
UMLS CUI-4
C0444930
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
Descripción

In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1522577
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C0162714
UMLS CUI [2,1]
C1522577
UMLS CUI [2,2]
C0444930
UMLS CUI [2,3]
C0674432
UMLS CUI [3,1]
C1522577
UMLS CUI [3,2]
C0444930
UMLS CUI [3,3]
C0292818
UMLS CUI [4,1]
C1522577
UMLS CUI [4,2]
C0444930
UMLS CUI [4,3]
C1435444
UMLS CUI [5,1]
C1522577
UMLS CUI [5,2]
C0444930
UMLS CUI [5,3]
C1145759
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
Descripción

In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1522577
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C0376601
UMLS CUI [2,1]
C1522577
UMLS CUI [2,2]
C0444930
UMLS CUI [2,3]
C1871526
UMLS CUI [3,1]
C1522577
UMLS CUI [3,2]
C0444930
UMLS CUI [3,3]
C3253985
UMLS CUI [4,1]
C1522577
UMLS CUI [4,2]
C0444930
UMLS CUI [4,3]
C4507568
UMLS CUI [5,1]
C1522577
UMLS CUI [5,2]
C0444930
UMLS CUI [5,3]
C2606637
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Descripción

In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1522577
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C3541376
UMLS CUI [2,1]
C1522577
UMLS CUI [2,2]
C0444930
UMLS CUI [2,3]
C0674428
UMLS CUI [3,1]
C1522577
UMLS CUI [3,2]
C0444930
UMLS CUI [3,3]
C0132326
UMLS CUI [4,1]
C1522577
UMLS CUI [4,2]
C0444930
UMLS CUI [4,3]
C1566826
UMLS CUI [5,1]
C1522577
UMLS CUI [5,2]
C0444930
UMLS CUI [5,3]
C4045491
Nucleoside analog reverse-transcriptase inhibitors
Descripción

In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1522577
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C3537103
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
Descripción

In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1522577
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C1449715
UMLS CUI [2,1]
C1522577
UMLS CUI [2,2]
C0444930
UMLS CUI [2,3]
C1667052
UMLS CUI [3,1]
C1522577
UMLS CUI [3,2]
C0444930
UMLS CUI [3,3]
C0537439
CD4+ T-cell count (abs.)
Descripción

CD4+ T-cell count (abs.)

Alias
UMLS CUI-1
C1277776
CD4+ (abs): Before SARS-CoV-2 detection
Descripción

Please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
CD4+ (abs): Baseline (at SARS-CoV-2 detection)
Descripción

Please indicate the lowest count at SARS-CoV-2 detection. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C1442488
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
CD4+ (abs): Uncomplicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C0443334
UMLS CUI [1,3]
C0205390
CD4+ (abs): Complicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C0231242
UMLS CUI [1,3]
C0205390
CD4+ (abs): Critical phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C1511545
UMLS CUI [1,3]
C0205390
CD4+ (abs): Recovery phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C0205390
CD4+ T-cell count (rel.)
Descripción

CD4+ T-cell count (rel.)

Alias
UMLS CUI-1
C2698595
UMLS CUI-2
C0205345
CD4+ (rel): Before SARS-CoV-2 detection
Descripción

Please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
CD4+ (rel): Baseline (at SARS-CoV-2 detection)
Descripción

Please indicate the lowest count at SARS-CoV-2 detection. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C1442488
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
CD4+ (rel): Uncomplicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
CD4+ (rel): Complicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0231242
UMLS CUI [1,4]
C0205390
CD4+ (rel): Critical phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C1511545
UMLS CUI [1,4]
C0205390
CD4+ (rel): Recovery phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C2004454
UMLS CUI [1,4]
C0205390
Please indicate the CDC stage at baseline
Descripción

Please indicate the CDC stage at baseline

Alias
UMLS CUI-1
C1272816
UMLS CUI-2
C1442488
Please indicate the CDC stage at baseline
Descripción

CDC stages are mainly defined by CD4 count (see figure on the following website), or stage-3-defining illness which can be revised at https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm?s_cid=rr6303a1_e

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1272816
UMLS CUI [1,2]
C1442488
CD8+ T-cell count (abs.)
Descripción

CD8+ T-cell count (abs.)

Alias
UMLS CUI-1
C1277777
CD8+ (abs): Before SARS-CoV-2 detection
Descripción

Please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
CD8+ (abs): Baseline (at SARS-CoV-2 detection)
Descripción

Please indicate the lowest count at SARS-CoV-2 detection. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C1442488
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
CD8+ (abs): Uncomplicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C0443334
UMLS CUI [1,3]
C0205390
CD8+ (abs): Complicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C0231242
UMLS CUI [1,3]
C0205390
CD8+ (abs): Critical phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C1511545
UMLS CUI [1,3]
C0205390
CD8+ (abs): Recovery phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C0205390
CD8+ T-cell count (rel.)
Descripción

CD8+ T-cell count (rel.)

Alias
UMLS CUI-1
C2698600
UMLS CUI-2
C0205345
CD8+ (rel): Before SARS-CoV-2 detection
Descripción

Please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
CD8+ (rel): Baseline (at SARS-CoV-2 detection)
Descripción

Please indicate the lowest count at SARS-CoV-2 detection. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C1442488
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
CD8+ (rel): Uncomplicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
CD8+ (rel): Complicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0231242
UMLS CUI [1,4]
C0205390
CD8+ (rel): Critical phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C1511545
UMLS CUI [1,4]
C0205390
CD8+ (rel): Recovery phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C2004454
UMLS CUI [1,4]
C0205390
Viral load
Descripción

Viral load

Alias
UMLS CUI-1
C1168369
HIV viral load: Before SARS-CoV-2 detection
Descripción

Please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
HIV viral load: Baseline (at SARS-CoV-2 detection)
Descripción

Please indicate the lowest count at SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C1442488
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
HIV viral load: Uncomplicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C0443334
UMLS CUI [1,3]
C0205390
HIV viral load: Complicated phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C0231242
UMLS CUI [1,3]
C0205390
HIV viral load: Critical phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C1511545
UMLS CUI [1,3]
C0205390
HIV viral load: Recovery phase
Descripción

Please indicate the lowest count during the whole phase. If no information is available select unknown.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C0205390
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
Descripción

Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?

Alias
UMLS CUI-1
C0029118
UMLS CUI-2
C0740830
UMLS CUI-3
C0036916
UMLS CUI-4
C5203670
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
Descripción

Opportunistic infections, AIDS-defining illnesses, STI during COVID-19

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0029118
UMLS CUI [1,2]
C5203670
UMLS CUI [2,1]
C0740830
UMLS CUI [2,2]
C5203670
UMLS CUI [3,1]
C0036916
UMLS CUI [3,2]
C5203670
Indicate opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection):
Descripción

Indicate opportunistic infections, AIDS-defining illnesses, STI during COVID-19

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1521902
UMLS CUI [1,2]
C0029118
UMLS CUI [1,3]
C5203670
UMLS CUI [2,1]
C1521902
UMLS CUI [2,2]
C0740830
UMLS CUI [2,3]
C5203670
UMLS CUI [3,1]
C1521902
UMLS CUI [3,2]
C0036916
UMLS CUI [3,3]
C5203670
Is data entry for this section finished?
Descripción

Is data entry for this section finished?

Alias
UMLS CUI-1
C4684556
UMLS CUI-2
C1828479
UMLS CUI-3
C0205197
Is data entry for this section finished?
Descripción

Is data entry for this section finished?

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C4684556
UMLS CUI [1,2]
C1828479
UMLS CUI [1,3]
C0205197
Volver a la parte superior de la página

Similar models

HIV sub-cohort

1 formularios
  1. StudyEvent: ODM
    1. HIV sub-cohort
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
HIV transmission risk
C0019682 (UMLS CUI-1)
C0035648 (UMLS CUI-2)
C1443844 (UMLS CUI-3)
Men having sex with men
Item
Men having sex with men
boolean
C2827413 (UMLS CUI [1])
Heterosexual contacts
Item
Heterosexual contacts
boolean
C4272228 (UMLS CUI [1])
Injection drug use
Item
Injection drug use
boolean
C0086190 (UMLS CUI [1,1])
C1272883 (UMLS CUI [1,2])
Patient from HIV endemic area
Item
Patient from an endemic area
boolean
C3258107 (UMLS CUI [1,1])
C0277550 (UMLS CUI [1,2])
C0019682 (UMLS CUI [1,3])
Blood transfusion (excl. Haemophilia)
Item
Blood transfusion (excl. Haemophilia)
boolean
C0005841 (UMLS CUI [1,1])
C1705847 (UMLS CUI [1,2])
C0684275 (UMLS CUI [1,3])
Haemophilia
Item
Haemophilia
boolean
C0684275 (UMLS CUI [1])
Other HIV transmission risk
Item
Other HIV transmission risk
boolean
C0019682 (UMLS CUI [1,1])
C0035648 (UMLS CUI [1,2])
C1443844 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
Indicate other HIV transmission risk
Item
Indicate other HIV transmission risk:
text
C0019682 (UMLS CUI [1,1])
C0035648 (UMLS CUI [1,2])
C1443844 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C1521902 (UMLS CUI [1,5])
Unknown HIV transmission risk
Item
Unknown HIV transmission risk
boolean
C0439673 (UMLS CUI [1,1])
C0035648 (UMLS CUI [1,2])
C1443844 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
Item Group
Does the patient receive current antiretroviral therapy?
C1963724 (UMLS CUI-1)
C0521116 (UMLS CUI-2)
Item
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
integer
C0521116 (UMLS CUI [1,1])
C0162714 (UMLS CUI [1,2])
C0521116 (UMLS CUI [2,1])
C0674432 (UMLS CUI [2,2])
C0521116 (UMLS CUI [3,1])
C0292818 (UMLS CUI [3,2])
C0521116 (UMLS CUI [4,1])
C1435444 (UMLS CUI [4,2])
C0521116 (UMLS CUI [5,1])
C1145759 (UMLS CUI [5,2])
Gender
Code List
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
integer
C0521116 (UMLS CUI [1,1])
C0376601 (UMLS CUI [1,2])
C0521116 (UMLS CUI [2,1])
C1871526 (UMLS CUI [2,2])
C0521116 (UMLS CUI [3,1])
C3253985 (UMLS CUI [3,2])
C0521116 (UMLS CUI [4,1])
C4507568 (UMLS CUI [4,2])
C0521116 (UMLS CUI [5,1])
C2606637 (UMLS CUI [5,2])
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
Code List
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
integer
C0521116 (UMLS CUI [1,1])
C3541376 (UMLS CUI [1,2])
C0521116 (UMLS CUI [2,1])
C0674428 (UMLS CUI [2,2])
C0521116 (UMLS CUI [3,1])
C0132326 (UMLS CUI [3,2])
C0521116 (UMLS CUI [4,1])
C1566826 (UMLS CUI [4,2])
C0521116 (UMLS CUI [5,1])
C4045491 (UMLS CUI [5,2])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Nucleoside analog reverse-transcriptase inhibitors
integer
C0521116 (UMLS CUI [1,1])
C3537103 (UMLS CUI [1,2])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Nucleoside analog reverse-transcriptase inhibitors
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
integer
C0521116 (UMLS CUI [1,1])
C1449715 (UMLS CUI [1,2])
C0521116 (UMLS CUI [2,1])
C1667052 (UMLS CUI [2,2])
C0521116 (UMLS CUI [3,1])
C0537439 (UMLS CUI [3,2])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
C1963724 (UMLS CUI-1)
C0449238 (UMLS CUI-2)
C0332152 (UMLS CUI-3)
C5203676 (UMLS CUI-4)
C1511790 (UMLS CUI-5)
Item
In case of antiretroviral therapy: for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
integer
C1963724 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
undefined item
Code List
In case of antiretroviral therapy: for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
CL Item
< 3 months (1)
CL Item
3 - 6 months (2)
CL Item
> 6 months (3)
CL Item
Unknown (4)
CL Item
No antiretroviral therapy (5)
Item Group
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
C1963724 (UMLS CUI-1)
C3665894 (UMLS CUI-2)
C1704686 (UMLS CUI-3)
C0347984 (UMLS CUI-5)
C5203670 (UMLS CUI-6)
Item
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
integer
C1963724 (UMLS CUI [1,1])
C3665894 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C5203670 (UMLS CUI [1,4])
C1963724 (UMLS CUI [2,1])
C1704686 (UMLS CUI [2,2])
C0347984 (UMLS CUI [2,3])
C5203670 (UMLS CUI [2,4])
undefined item
Code List
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Please indicate the regimen at the end of the follow-up period
C1963724 (UMLS CUI-1)
C1276413 (UMLS CUI-2)
C1522577 (UMLS CUI-3)
C0444930 (UMLS CUI-4)
Item
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
integer
C1522577 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C0162714 (UMLS CUI [1,3])
C1522577 (UMLS CUI [2,1])
C0444930 (UMLS CUI [2,2])
C0674432 (UMLS CUI [2,3])
C1522577 (UMLS CUI [3,1])
C0444930 (UMLS CUI [3,2])
C0292818 (UMLS CUI [3,3])
C1522577 (UMLS CUI [4,1])
C0444930 (UMLS CUI [4,2])
C1435444 (UMLS CUI [4,3])
C1522577 (UMLS CUI [5,1])
C0444930 (UMLS CUI [5,2])
C1145759 (UMLS CUI [5,3])
Gender
Code List
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
integer
C1522577 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C0376601 (UMLS CUI [1,3])
C1522577 (UMLS CUI [2,1])
C0444930 (UMLS CUI [2,2])
C1871526 (UMLS CUI [2,3])
C1522577 (UMLS CUI [3,1])
C0444930 (UMLS CUI [3,2])
C3253985 (UMLS CUI [3,3])
C1522577 (UMLS CUI [4,1])
C0444930 (UMLS CUI [4,2])
C4507568 (UMLS CUI [4,3])
C1522577 (UMLS CUI [5,1])
C0444930 (UMLS CUI [5,2])
C2606637 (UMLS CUI [5,3])
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
Code List
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
integer
C1522577 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C3541376 (UMLS CUI [1,3])
C1522577 (UMLS CUI [2,1])
C0444930 (UMLS CUI [2,2])
C0674428 (UMLS CUI [2,3])
C1522577 (UMLS CUI [3,1])
C0444930 (UMLS CUI [3,2])
C0132326 (UMLS CUI [3,3])
C1522577 (UMLS CUI [4,1])
C0444930 (UMLS CUI [4,2])
C1566826 (UMLS CUI [4,3])
C1522577 (UMLS CUI [5,1])
C0444930 (UMLS CUI [5,2])
C4045491 (UMLS CUI [5,3])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Nucleoside analog reverse-transcriptase inhibitors
integer
C1522577 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C3537103 (UMLS CUI [1,3])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Nucleoside analog reverse-transcriptase inhibitors
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
integer
C1522577 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C1449715 (UMLS CUI [1,3])
C1522577 (UMLS CUI [2,1])
C0444930 (UMLS CUI [2,2])
C1667052 (UMLS CUI [2,3])
C1522577 (UMLS CUI [3,1])
C0444930 (UMLS CUI [3,2])
C0537439 (UMLS CUI [3,3])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
CD4+ T-cell count (abs.)
C1277776 (UMLS CUI-1)
Item
CD4+ (abs): Before SARS-CoV-2 detection
integer
C1277776 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
CD4+ (abs): Before SARS-CoV-2 detection
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (abs): Baseline (at SARS-CoV-2 detection)
integer
C1277776 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
CD4+ (abs): Baseline (at SARS-CoV-2 detection)
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (abs): Uncomplicated phase
integer
C1277776 (UMLS CUI [1,1])
C0443334 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
Before SARS-CoV-2 detection
Code List
CD4+ (abs): Uncomplicated phase
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (abs): Complicated phase
integer
C1277776 (UMLS CUI [1,1])
C0231242 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
Before SARS-CoV-2 detection
Code List
CD4+ (abs): Complicated phase
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (abs): Critical phase
integer
C1277776 (UMLS CUI [1,1])
C1511545 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
Before SARS-CoV-2 detection
Code List
CD4+ (abs): Critical phase
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (abs): Recovery phase
integer
C1277776 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
Before SARS-CoV-2 detection
Code List
CD4+ (abs): Recovery phase
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item Group
CD4+ T-cell count (rel.)
C2698595 (UMLS CUI-1)
C0205345 (UMLS CUI-2)
Item
CD4+ (rel): Before SARS-CoV-2 detection
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
Before SARS-CoV-2 detection
Code List
CD4+ (rel): Before SARS-CoV-2 detection
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (rel): Baseline (at SARS-CoV-2 detection)
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
Before SARS-CoV-2 detection
Code List
CD4+ (rel): Baseline (at SARS-CoV-2 detection)
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (rel): Uncomplicated phase
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
CD4+ (rel): Uncomplicated phase
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (rel): Complicated phase
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0231242 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
CD4+ (rel): Complicated phase
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (rel): Critical phase
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C1511545 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
CD4+ (rel): Critical phase
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD4+ (rel): Recovery phase
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C2004454 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
CD4+ (rel): Recovery phase
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item Group
Please indicate the CDC stage at baseline
C1272816 (UMLS CUI-1)
C1442488 (UMLS CUI-2)
Item
Please indicate the CDC stage at baseline
integer
C1272816 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
HIV CDC stage at baseline
Code List
Please indicate the CDC stage at baseline
CL Item
Stage 1 (1)
CL Item
Stage 2 (2)
CL Item
Stage 3 (3)
CL Item
Unknown (4)
Item Group
CD8+ T-cell count (abs.)
C1277777 (UMLS CUI-1)
Item
CD8+ (abs): Before SARS-CoV-2 detection
integer
C1277777 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
CD8+ (abs): Before SARS-CoV-2 detection
Code List
CD8+ (abs): Before SARS-CoV-2 detection
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (abs): Baseline (at SARS-CoV-2 detection)
integer
C1277777 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
CD8+ (abs): Baseline (at SARS-CoV-2 detection)
Code List
CD8+ (abs): Baseline (at SARS-CoV-2 detection)
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (abs): Uncomplicated phase
integer
C1277777 (UMLS CUI [1,1])
C0443334 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (abs): Uncomplicated phase
Code List
CD8+ (abs): Uncomplicated phase
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (abs): Complicated phase
integer
C1277777 (UMLS CUI [1,1])
C0231242 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (abs): Complicated phase
Code List
CD8+ (abs): Complicated phase
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (abs): Critical phase
integer
C1277777 (UMLS CUI [1,1])
C1511545 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (abs): Critical phase
Code List
CD8+ (abs): Critical phase
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (abs): Recovery phase
integer
C1277777 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (abs): Recovery phase
Code List
CD8+ (abs): Recovery phase
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item Group
CD8+ T-cell count (rel.)
C2698600 (UMLS CUI-1)
C0205345 (UMLS CUI-2)
Item
CD8+ (rel): Before SARS-CoV-2 detection
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
CD8+ (rel): Before SARS-CoV-2 detection
Code List
CD8+ (rel): Before SARS-CoV-2 detection
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (rel): Baseline (at SARS-CoV-2 detection)
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
CD8+ (rel): Baseline (at SARS-CoV-2 detection)
Code List
CD8+ (rel): Baseline (at SARS-CoV-2 detection)
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (rel): Uncomplicated phase
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
CD8+ (rel): Uncomplicated phase
Code List
CD8+ (rel): Uncomplicated phase
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (rel): Complicated phase
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0231242 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
CD8+ (rel): Complicated phase
Code List
CD8+ (rel): Complicated phase
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (rel): Critical phase
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C1511545 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
CD8+ (rel): Critical phase
Code List
CD8+ (rel): Critical phase
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
CD8+ (rel): Recovery phase
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C2004454 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
CD8+ (rel): Recovery phase
Code List
CD8+ (rel): Recovery phase
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item Group
Viral load
C1168369 (UMLS CUI-1)
Item
HIV viral load: Before SARS-CoV-2 detection
integer
C1168369 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
CD8+ (rel): Before SARS-CoV-2 detection
Code List
HIV viral load: Before SARS-CoV-2 detection
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
HIV viral load: Baseline (at SARS-CoV-2 detection)
integer
C1168369 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
CD8+ (rel): Baseline (at SARS-CoV-2 detection)
Code List
HIV viral load: Baseline (at SARS-CoV-2 detection)
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
HIV viral load: Uncomplicated phase
integer
C1168369 (UMLS CUI [1,1])
C0443334 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (rel): Uncomplicated phase
Code List
HIV viral load: Uncomplicated phase
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
HIV viral load: Complicated phase
integer
C1168369 (UMLS CUI [1,1])
C0231242 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (rel): Complicated phase
Code List
HIV viral load: Complicated phase
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
HIV viral load: Critical phase
integer
C1168369 (UMLS CUI [1,1])
C1511545 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (rel): Critical phase
Code List
HIV viral load: Critical phase
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
HIV viral load: Recovery phase
integer
C1168369 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (rel): Recovery phase
Code List
HIV viral load: Recovery phase
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item Group
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
C0029118 (UMLS CUI-1)
C0740830 (UMLS CUI-2)
C0036916 (UMLS CUI-3)
C5203670 (UMLS CUI-4)
Item
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
integer
C0029118 (UMLS CUI [1,1])
C5203670 (UMLS CUI [1,2])
C0740830 (UMLS CUI [2,1])
C5203670 (UMLS CUI [2,2])
C0036916 (UMLS CUI [3,1])
C5203670 (UMLS CUI [3,2])
Opportunistic infections, AIDS-defining illnesses, STI during SARS-CoV-2
Code List
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate opportunistic infections, AIDS-defining illnesses, STI during COVID-19
Item
Indicate opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection):
text
C1521902 (UMLS CUI [1,1])
C0029118 (UMLS CUI [1,2])
C5203670 (UMLS CUI [1,3])
C1521902 (UMLS CUI [2,1])
C0740830 (UMLS CUI [2,2])
C5203670 (UMLS CUI [2,3])
C1521902 (UMLS CUI [3,1])
C0036916 (UMLS CUI [3,2])
C5203670 (UMLS CUI [3,3])
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Item
Is data entry for this section finished?
integer
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
BL_Completed
Code List
Is data entry for this section finished?
CL Item
Yes (1)
CL Item
No (2)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial